GB2355404A - Vinegar for treating parasites - Google Patents
Vinegar for treating parasites Download PDFInfo
- Publication number
- GB2355404A GB2355404A GB9919835A GB9919835A GB2355404A GB 2355404 A GB2355404 A GB 2355404A GB 9919835 A GB9919835 A GB 9919835A GB 9919835 A GB9919835 A GB 9919835A GB 2355404 A GB2355404 A GB 2355404A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vinegar
- parasites
- treating parasites
- apple cider
- cider vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Aqueous solutions of apple cider vinegar display activity against parasite infestations in mammals. The solutions are for drinking (oral administration).
Description
2355404 PARASITICAL ELIMINATION PROCESS Most parasites that infect men and
domestic animals survive in the host due to the ionic strength of the body fluids. They require supplementation with additional growth and primary survival factors, such as hormones, transport, proteins and trace elements, and essentially the correct pH factors, without such the parasites cannot survive. Traditionally, plasma, which of course is part of the bodily fluids, has been the supplementary transport mechanism to provide these factors.
During parasite separation (using ion exchange chromatography), it has been noted that parasites will only survive in a pH range between 7.0 and 8.0 without any shrinkage or denaturing of the protein outer cell membrane. When there is a drastic change in pH, either towards acidity or alkaline levels outside of the normal pH levels, the parasites begin to die.
Recently, further studies conducted by the inventor, established that even a marginal reduction in pH, (typically down to 6.5 in acidity), that all the parasites die rapidly. The increase in hydrogen ions in an acidic condition alters the protein structures (denaturization of the parasite). The separation of hydrogen bonding from the oxygen atoms alters the structure of the proteins and nucleic acids.
With this obvious but nonetheless exciting observation the next stage was to examine an effective and healthy way of altering the pH in in vivo applications, without creating unnecessary chemical imbalances to the patient. Following exhaustive testing, the following solution was determined. The person suffering from parasitical invasion should drink three hundred (300-ml) millilitres of distilled water with a 1.5% by volume of acidity level of apple cider vinegar, to be taken four times per day. If this regime is adhered to, the infestation of parasites in the patient will be eliminated.
I z CLAIMS:
I 1. The use of a vinegar in the manufacture of a medicament for the treatment or prophylaxis of parasite-caused diseases in a mammal.
2. The use according to claim 1, wherein the vinegar is apple cider vinegar.
3. The use according to claim 2, wherein a 1.5% by volume aqueous solution of apple cider vinegar is used.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9919835A GB2355404A (en) | 1999-08-20 | 1999-08-20 | Vinegar for treating parasites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9919835A GB2355404A (en) | 1999-08-20 | 1999-08-20 | Vinegar for treating parasites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9919835D0 GB9919835D0 (en) | 1999-10-27 |
| GB2355404A true GB2355404A (en) | 2001-04-25 |
Family
ID=10859575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9919835A Withdrawn GB2355404A (en) | 1999-08-20 | 1999-08-20 | Vinegar for treating parasites |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2355404A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1593601A (en) * | 1976-11-22 | 1981-07-22 | Sertog | Insecticide composition |
| EP0736251A1 (en) * | 1995-04-07 | 1996-10-09 | Joseph Benwaiche | Antiparasitic lotion |
| WO1998025586A1 (en) * | 1996-12-10 | 1998-06-18 | Patricia Dupuy | Preparation for dermatological use |
| WO1998029112A1 (en) * | 1997-01-02 | 1998-07-09 | Melman Steven A | Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina |
| GB2347082A (en) * | 1999-02-24 | 2000-08-30 | Margaret Mary Seale | Treatment or prevention of parasitic infection using acetic acid |
-
1999
- 1999-08-20 GB GB9919835A patent/GB2355404A/en not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1593601A (en) * | 1976-11-22 | 1981-07-22 | Sertog | Insecticide composition |
| EP0736251A1 (en) * | 1995-04-07 | 1996-10-09 | Joseph Benwaiche | Antiparasitic lotion |
| WO1998025586A1 (en) * | 1996-12-10 | 1998-06-18 | Patricia Dupuy | Preparation for dermatological use |
| WO1998029112A1 (en) * | 1997-01-02 | 1998-07-09 | Melman Steven A | Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina |
| GB2347082A (en) * | 1999-02-24 | 2000-08-30 | Margaret Mary Seale | Treatment or prevention of parasitic infection using acetic acid |
Non-Patent Citations (1)
| Title |
|---|
| Proc. NZ Soc. Animal Prod., 53, 413-5, (1993) * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9919835D0 (en) | 1999-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thummasorn et al. | Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction | |
| Valacchi et al. | Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells | |
| KR101499822B1 (en) | Methods of treating or preventing sinusitis with oxidative reductive potential water solution | |
| Knoell et al. | Impact of zinc metabolism on innate immune function in the setting of sepsis | |
| Park et al. | Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3 | |
| WO2009128279A1 (en) | Composition for oral ingestion | |
| Seo et al. | Inhibitory effects of methanol extract of seeds of job's tears (Coix Lachryma-Jobi L Var. Ma-Yuen) on nitric oxide and superoxide production in raw 264.7 macrophages | |
| Min-Chang et al. | Effects of Selenium‐Enriched Protein from Ganoderma lucidum on the Levels of IL‐1β and TNF‐α, Oxidative Stress, and NF‐κB Activation in Ovalbumin‐Induced Asthmatic Mice | |
| Kim et al. | Effects of polysaccharides from rhizomes of Curcuma zedoaria on macrophage functions | |
| EP1719517B1 (en) | Artificial physiological salt solution and process for producing the same | |
| US20200246403A1 (en) | Yeast extract having diabetes prevention effect | |
| Sun et al. | Saxagliptin alleviates erectile dysfunction through increasing stromal cell‐derived factor‐1 in diabetes mellitus | |
| EP1425047A4 (en) | Method for improving oxygen transport by stored red blood cells | |
| Nicosia et al. | Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas: Stimulation of PRL release and activation of adenylate cyclase | |
| Dou et al. | Biogenic selenium nanoparticles alleviate intestinal epithelial barrier injury by regulating mitochondria–lysosome crosstalk | |
| Das et al. | Time-dependent effects of ethanol on blood oxidative stress parameters and cytokines | |
| CN105848624B (en) | Immersion system | |
| GB2355404A (en) | Vinegar for treating parasites | |
| Hong et al. | Influences of hexamethonium and some dietary factors on human pancreatic and bile secretion | |
| Ženíšková et al. | Copper metabolism in Naegleria gruberi and its deadly relative Naegleria fowleri | |
| Shirato et al. | Enzyme-treated asparagus extract prevents hydrogen peroxide-induced pro-inflammatory responses by suppressing p65 nuclear translocation in skin L929 fibroblasts | |
| KR20210044473A (en) | Enzyme composition exhibiting an inflammatory response suppressing or modulating activity | |
| Yaghchi et al. | Comparing the effects of Saccharomyces boulardii and selenium-enriched S. boulardii on hematological parameters and total antioxidant capacity in aluminum induced toxicity in rats | |
| Chen et al. | Molecular Hydrogen Suppresses Renal Injury in Chronic Kidney Disease Rats | |
| Terziev et al. | Effects of L-2-oxоthiazolidine-4-carboxylic acid on the lung antioxidant defense system in an asthma mouse model |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |